Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

BACKGROUND: In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option. METHODS: In this open-label, single-center, case–control pilot...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajnc, Nik, Itariu, Bianca, Macher, Stefan, Marik, Wolfgang, Harreiter, Jürgen, Michl, Martin, Novak, Klaus, Wöber, Christian, Pemp, Berthold, Bsteh, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353241/
https://www.ncbi.nlm.nih.gov/pubmed/37460968
http://dx.doi.org/10.1186/s10194-023-01631-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353241/
https://www.ncbi.nlm.nih.gov/pubmed/37460968
http://dx.doi.org/10.1186/s10194-023-01631-z

Ejemplares similares